About
Synthesize Bio develops generative genomics models that simulate human tissue and cellular responses to drugs and diseases, enabling biopharma teams to optimize clinical trial design and drug development decisions using synthetic patient data.
Explore Synthesize Bio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.